91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Continuous Glucose Monitoring (CGM) Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Continuous Glucose Monitoring (CGM) Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID: 
PB511241492
Publication Date: 
November 25, 2024
Pages: 
82
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 3,950.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

IT Services [2]
Hardware (Computing & Electronics) [3]
Computing & Electronics [4]
Description: 

The global market for Continuous Glucose Monitoring (CGM) Technology was estimated to be worth US$ 7538.3 million in 2023 and is forecast to a readjusted size of US$ 20580 million by 2030 with a CAGR of 15.8% during the forecast period 2024-2030
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Continuous Glucose Monitoring (CGM) Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Continuous Glucose Monitoring (CGM) Technology by region & country, by Type, and by Application.
The Continuous Glucose Monitoring (CGM) Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Glucose Monitoring (CGM) Technology.
Market Segmentation
By Company
DexCom, Inc.
Medtronic
Abbott Laboratories
Sinocare Inc.
DirectSens
Senseonics
San MediTech
Medtrum Technologies Inc.
Segment by Type:
First Generation
Second Generation
Third Generation
Segment by Application
Household
Medical Institution
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Continuous Glucose Monitoring (CGM) Technology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Continuous Glucose Monitoring (CGM) Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Continuous Glucose Monitoring (CGM) Technology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Market Overview
1.1 Continuous Glucose Monitoring (CGM) Technology Product Introduction
1.2 Global Continuous Glucose Monitoring (CGM) Technology Market Size Forecast
1.3 Continuous Glucose Monitoring (CGM) Technology Market Trends & Drivers
1.3.1 Continuous Glucose Monitoring (CGM) Technology Industry Trends
1.3.2 Continuous Glucose Monitoring (CGM) Technology Market Drivers & Opportunity
1.3.3 Continuous Glucose Monitoring (CGM) Technology Market Challenges
1.3.4 Continuous Glucose Monitoring (CGM) Technology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Continuous Glucose Monitoring (CGM) Technology Players Revenue Ranking (2023)
2.2 Global Continuous Glucose Monitoring (CGM) Technology Revenue by Company (2019-2024)
2.3 Key Companies Continuous Glucose Monitoring (CGM) Technology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Continuous Glucose Monitoring (CGM) Technology Product Offered
2.5 Key Companies Time to Begin Mass Production of Continuous Glucose Monitoring (CGM) Technology
2.6 Continuous Glucose Monitoring (CGM) Technology Market Competitive Analysis
2.6.1 Continuous Glucose Monitoring (CGM) Technology Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Continuous Glucose Monitoring (CGM) Technology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Glucose Monitoring (CGM) Technology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 First Generation
3.1.2 Second Generation
3.1.3 Third Generation
3.2 Global Continuous Glucose Monitoring (CGM) Technology Sales Value by Type
3.2.1 Global Continuous Glucose Monitoring (CGM) Technology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Continuous Glucose Monitoring (CGM) Technology Sales Value, by Type (2019-2030)
3.2.3 Global Continuous Glucose Monitoring (CGM) Technology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Household
4.1.2 Medical Institution
4.2 Global Continuous Glucose Monitoring (CGM) Technology Sales Value by Application
4.2.1 Global Continuous Glucose Monitoring (CGM) Technology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Continuous Glucose Monitoring (CGM) Technology Sales Value, by Application (2019-2030)
4.2.3 Global Continuous Glucose Monitoring (CGM) Technology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Continuous Glucose Monitoring (CGM) Technology Sales Value by Region
5.1.1 Global Continuous Glucose Monitoring (CGM) Technology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Continuous Glucose Monitoring (CGM) Technology Sales Value by Region (2019-2024)
5.1.3 Global Continuous Glucose Monitoring (CGM) Technology Sales Value by Region (2025-2030)
5.1.4 Global Continuous Glucose Monitoring (CGM) Technology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Continuous Glucose Monitoring (CGM) Technology Sales Value, 2019-2030
5.2.2 North America Continuous Glucose Monitoring (CGM) Technology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Continuous Glucose Monitoring (CGM) Technology Sales Value, 2019-2030
5.3.2 Europe Continuous Glucose Monitoring (CGM) Technology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Continuous Glucose Monitoring (CGM) Technology Sales Value, 2019-2030
5.4.2 Asia Pacific Continuous Glucose Monitoring (CGM) Technology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Continuous Glucose Monitoring (CGM) Technology Sales Value, 2019-2030
5.5.2 South America Continuous Glucose Monitoring (CGM) Technology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Continuous Glucose Monitoring (CGM) Technology Sales Value, 2019-2030
5.6.2 Middle East & Africa Continuous Glucose Monitoring (CGM) Technology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Continuous Glucose Monitoring (CGM) Technology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Continuous Glucose Monitoring (CGM) Technology Sales Value
6.3 United States
6.3.1 United States Continuous Glucose Monitoring (CGM) Technology Sales Value, 2019-2030
6.3.2 United States Continuous Glucose Monitoring (CGM) Technology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Continuous Glucose Monitoring (CGM) Technology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Continuous Glucose Monitoring (CGM) Technology Sales Value, 2019-2030
6.4.2 Europe Continuous Glucose Monitoring (CGM) Technology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Continuous Glucose Monitoring (CGM) Technology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Continuous Glucose Monitoring (CGM) Technology Sales Value, 2019-2030
6.5.2 China Continuous Glucose Monitoring (CGM) Technology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Continuous Glucose Monitoring (CGM) Technology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Continuous Glucose Monitoring (CGM) Technology Sales Value, 2019-2030
6.6.2 Japan Continuous Glucose Monitoring (CGM) Technology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Continuous Glucose Monitoring (CGM) Technology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Continuous Glucose Monitoring (CGM) Technology Sales Value, 2019-2030
6.7.2 South Korea Continuous Glucose Monitoring (CGM) Technology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Continuous Glucose Monitoring (CGM) Technology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Continuous Glucose Monitoring (CGM) Technology Sales Value, 2019-2030
6.8.2 Southeast Asia Continuous Glucose Monitoring (CGM) Technology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Continuous Glucose Monitoring (CGM) Technology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Continuous Glucose Monitoring (CGM) Technology Sales Value, 2019-2030
6.9.2 India Continuous Glucose Monitoring (CGM) Technology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Continuous Glucose Monitoring (CGM) Technology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 DexCom, Inc.
7.1.1 DexCom, Inc. Profile
7.1.2 DexCom, Inc. Main Business
7.1.3 DexCom, Inc. Continuous Glucose Monitoring (CGM) Technology Products, Services and Solutions
7.1.4 DexCom, Inc. Continuous Glucose Monitoring (CGM) Technology Revenue (US$ Million) & (2019-2024)
7.1.5 DexCom, Inc. Recent Developments
7.2 Medtronic
7.2.1 Medtronic Profile
7.2.2 Medtronic Main Business
7.2.3 Medtronic Continuous Glucose Monitoring (CGM) Technology Products, Services and Solutions
7.2.4 Medtronic Continuous Glucose Monitoring (CGM) Technology Revenue (US$ Million) & (2019-2024)
7.2.5 Medtronic Recent Developments
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Profile
7.3.2 Abbott Laboratories Main Business
7.3.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) Technology Products, Services and Solutions
7.3.4 Abbott Laboratories Continuous Glucose Monitoring (CGM) Technology Revenue (US$ Million) & (2019-2024)
7.3.5 Sinocare Inc. Recent Developments
7.4 Sinocare Inc.
7.4.1 Sinocare Inc. Profile
7.4.2 Sinocare Inc. Main Business
7.4.3 Sinocare Inc. Continuous Glucose Monitoring (CGM) Technology Products, Services and Solutions
7.4.4 Sinocare Inc. Continuous Glucose Monitoring (CGM) Technology Revenue (US$ Million) & (2019-2024)
7.4.5 Sinocare Inc. Recent Developments
7.5 DirectSens
7.5.1 DirectSens Profile
7.5.2 DirectSens Main Business
7.5.3 DirectSens Continuous Glucose Monitoring (CGM) Technology Products, Services and Solutions
7.5.4 DirectSens Continuous Glucose Monitoring (CGM) Technology Revenue (US$ Million) & (2019-2024)
7.5.5 DirectSens Recent Developments
7.6 Senseonics
7.6.1 Senseonics Profile
7.6.2 Senseonics Main Business
7.6.3 Senseonics Continuous Glucose Monitoring (CGM) Technology Products, Services and Solutions
7.6.4 Senseonics Continuous Glucose Monitoring (CGM) Technology Revenue (US$ Million) & (2019-2024)
7.6.5 Senseonics Recent Developments
7.7 San MediTech
7.7.1 San MediTech Profile
7.7.2 San MediTech Main Business
7.7.3 San MediTech Continuous Glucose Monitoring (CGM) Technology Products, Services and Solutions
7.7.4 San MediTech Continuous Glucose Monitoring (CGM) Technology Revenue (US$ Million) & (2019-2024)
7.7.5 San MediTech Recent Developments
7.8 Medtrum Technologies Inc.
7.8.1 Medtrum Technologies Inc. Profile
7.8.2 Medtrum Technologies Inc. Main Business
7.8.3 Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) Technology Products, Services and Solutions
7.8.4 Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) Technology Revenue (US$ Million) & (2019-2024)
7.8.5 Medtrum Technologies Inc. Recent Developments
8 Industry Chain Analysis
8.1 Continuous Glucose Monitoring (CGM) Technology Industrial Chain
8.2 Continuous Glucose Monitoring (CGM) Technology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Continuous Glucose Monitoring (CGM) Technology Sales Model
8.5.2 Sales Channel
8.5.3 Continuous Glucose Monitoring (CGM) Technology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned: 

DexCom, Inc.
Medtronic
Abbott Laboratories
Sinocare Inc.
DirectSens
Senseonics
San MediTech
Medtrum Technologies Inc.

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/continuous-glucose-monitoring-cgm-technology-global-market-share-and-ranking-overall-sales

Links
[1] /countries/global[2] /it-services[3] /hardware-computing-electronics[4] /computing-electronics